VULM 1457
VULM 1457 is a potent ACAT inhibitor. VULM 1457 has remarkable hypolipidaemic activity and improves the overall myocardial ischaemia-reperfusion injury outcomes.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
449.57
Molecular Formula
C25H27N3O3S
Notes
Research use only, not for human use.
Receptor
——
CAS Number
228544-65-8
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1101757-01 0.02 mg (E-Coli)
Recombinant Shewanella pealeana 5'-nucleotidase surE (surE)
Ask
View Details 
MBS1101757-02 0.1 mg (E-Coli)
Recombinant Shewanella pealeana 5'-nucleotidase surE (surE)
Ask
View Details 
MBS1101757-03 0.02 mg (Baculovirus)
Recombinant Shewanella pealeana 5'-nucleotidase surE (surE)
Ask
View Details MBS1101757-04 0.02 mg (Mammalian-Cell)
Recombinant Shewanella pealeana 5'-nucleotidase surE (surE)
Ask
View Details MBS1101757-05 1 mg (E-Coli)
Recombinant Shewanella pealeana 5'-nucleotidase surE (surE)
Ask
View Details 
MBS1101757-06 0.1 mg (Baculovirus)
Recombinant Shewanella pealeana 5'-nucleotidase surE (surE)
Ask
View Details